An overlap-weighted analysis on the association of constipation symptoms with disease progression and survival in amyotrophic lateral sclerosis: a nested case-control study

Background: Amyotrophic lateral sclerosis (ALS) is a rapidly progressing and rare neurodegenerative disease. Therefore, evaluating the risk factors affecting the survival of patients with ALS is crucial. Constipation, a common but overlooked symptom of ALS, can be effectively managed. It is currentl...

Full description

Saved in:
Bibliographic Details
Main Authors: Tongyang Niu, Peize Wang, Xiaomeng Zhou, Tingting Liu, Qi Liu, Rui Li, Haitao Yang, Hui Dong, Yaling Liu
Format: Article
Language:English
Published: SAGE Publishing 2025-01-01
Series:Therapeutic Advances in Neurological Disorders
Online Access:https://doi.org/10.1177/17562864241309811
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841550988073238528
author Tongyang Niu
Peize Wang
Xiaomeng Zhou
Tingting Liu
Qi Liu
Rui Li
Haitao Yang
Hui Dong
Yaling Liu
author_facet Tongyang Niu
Peize Wang
Xiaomeng Zhou
Tingting Liu
Qi Liu
Rui Li
Haitao Yang
Hui Dong
Yaling Liu
author_sort Tongyang Niu
collection DOAJ
description Background: Amyotrophic lateral sclerosis (ALS) is a rapidly progressing and rare neurodegenerative disease. Therefore, evaluating the risk factors affecting the survival of patients with ALS is crucial. Constipation, a common but overlooked symptom of ALS, can be effectively managed. It is currently unknown whether constipation contributes to the progression and survival of ALS. Objectives: This study aimed to investigate the association between constipation and ALS development and survival using a novel overlap-weighted (OW) method to enhance the robustness and reliability of results. Design: This prospective matching nested case-control (NCC) study was conducted within an ongoing ALS cohort at the Second Hospital of Hebei Medical University. Baseline data were collected from patients meeting the inclusion and exclusion criteria, with constipation as the exposure factor. A 9-month follow-up was conducted, with death as the endpoint event. Methods: We primarily used the OW method in NCC studies to examine the association between constipation and ALS development and survival. Weighted Cox proportional hazards model was used to assess risk factors associated with overall survival. Survival differences between the two groups were analyzed using Kaplan-Meier’s plots and log-rank tests. Finally, the bioinformatic analysis explored common pathways between ALS and constipation. Results: Among the 190 patients included, the prevalence of constipation was 50%. Patients with ALS constipation exhibited faster disease progression ( p  < 0.001), with a positive correlation between constipation severity and progression rate ( r  = 0.356, p  < 0.001). The constipation group had poorer survival before and after OW (log-rank test, p  < 0.0001). In the Cox proportional hazards model of 114 patients, constipation was a risk factor for ALS both before (hazard ratio (HR) = 5.840, 95% confidence interval (CI) = 1.504–22.675, p  = 0.011) and after (HR = 5.271, 95% CI = 1.241–22.379, p  = 0.024) OW. Conclusion: Constipation in individuals with ALS is associated with faster disease progression and reduced survival rates, potentially through the peroxisome proliferator-activated receptor pathway.
format Article
id doaj-art-57a51803c93547f19b80ed980212ef64
institution Kabale University
issn 1756-2864
language English
publishDate 2025-01-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Neurological Disorders
spelling doaj-art-57a51803c93547f19b80ed980212ef642025-01-09T18:03:20ZengSAGE PublishingTherapeutic Advances in Neurological Disorders1756-28642025-01-011810.1177/17562864241309811An overlap-weighted analysis on the association of constipation symptoms with disease progression and survival in amyotrophic lateral sclerosis: a nested case-control studyTongyang NiuPeize WangXiaomeng ZhouTingting LiuQi LiuRui LiHaitao YangHui DongYaling LiuBackground: Amyotrophic lateral sclerosis (ALS) is a rapidly progressing and rare neurodegenerative disease. Therefore, evaluating the risk factors affecting the survival of patients with ALS is crucial. Constipation, a common but overlooked symptom of ALS, can be effectively managed. It is currently unknown whether constipation contributes to the progression and survival of ALS. Objectives: This study aimed to investigate the association between constipation and ALS development and survival using a novel overlap-weighted (OW) method to enhance the robustness and reliability of results. Design: This prospective matching nested case-control (NCC) study was conducted within an ongoing ALS cohort at the Second Hospital of Hebei Medical University. Baseline data were collected from patients meeting the inclusion and exclusion criteria, with constipation as the exposure factor. A 9-month follow-up was conducted, with death as the endpoint event. Methods: We primarily used the OW method in NCC studies to examine the association between constipation and ALS development and survival. Weighted Cox proportional hazards model was used to assess risk factors associated with overall survival. Survival differences between the two groups were analyzed using Kaplan-Meier’s plots and log-rank tests. Finally, the bioinformatic analysis explored common pathways between ALS and constipation. Results: Among the 190 patients included, the prevalence of constipation was 50%. Patients with ALS constipation exhibited faster disease progression ( p  < 0.001), with a positive correlation between constipation severity and progression rate ( r  = 0.356, p  < 0.001). The constipation group had poorer survival before and after OW (log-rank test, p  < 0.0001). In the Cox proportional hazards model of 114 patients, constipation was a risk factor for ALS both before (hazard ratio (HR) = 5.840, 95% confidence interval (CI) = 1.504–22.675, p  = 0.011) and after (HR = 5.271, 95% CI = 1.241–22.379, p  = 0.024) OW. Conclusion: Constipation in individuals with ALS is associated with faster disease progression and reduced survival rates, potentially through the peroxisome proliferator-activated receptor pathway.https://doi.org/10.1177/17562864241309811
spellingShingle Tongyang Niu
Peize Wang
Xiaomeng Zhou
Tingting Liu
Qi Liu
Rui Li
Haitao Yang
Hui Dong
Yaling Liu
An overlap-weighted analysis on the association of constipation symptoms with disease progression and survival in amyotrophic lateral sclerosis: a nested case-control study
Therapeutic Advances in Neurological Disorders
title An overlap-weighted analysis on the association of constipation symptoms with disease progression and survival in amyotrophic lateral sclerosis: a nested case-control study
title_full An overlap-weighted analysis on the association of constipation symptoms with disease progression and survival in amyotrophic lateral sclerosis: a nested case-control study
title_fullStr An overlap-weighted analysis on the association of constipation symptoms with disease progression and survival in amyotrophic lateral sclerosis: a nested case-control study
title_full_unstemmed An overlap-weighted analysis on the association of constipation symptoms with disease progression and survival in amyotrophic lateral sclerosis: a nested case-control study
title_short An overlap-weighted analysis on the association of constipation symptoms with disease progression and survival in amyotrophic lateral sclerosis: a nested case-control study
title_sort overlap weighted analysis on the association of constipation symptoms with disease progression and survival in amyotrophic lateral sclerosis a nested case control study
url https://doi.org/10.1177/17562864241309811
work_keys_str_mv AT tongyangniu anoverlapweightedanalysisontheassociationofconstipationsymptomswithdiseaseprogressionandsurvivalinamyotrophiclateralsclerosisanestedcasecontrolstudy
AT peizewang anoverlapweightedanalysisontheassociationofconstipationsymptomswithdiseaseprogressionandsurvivalinamyotrophiclateralsclerosisanestedcasecontrolstudy
AT xiaomengzhou anoverlapweightedanalysisontheassociationofconstipationsymptomswithdiseaseprogressionandsurvivalinamyotrophiclateralsclerosisanestedcasecontrolstudy
AT tingtingliu anoverlapweightedanalysisontheassociationofconstipationsymptomswithdiseaseprogressionandsurvivalinamyotrophiclateralsclerosisanestedcasecontrolstudy
AT qiliu anoverlapweightedanalysisontheassociationofconstipationsymptomswithdiseaseprogressionandsurvivalinamyotrophiclateralsclerosisanestedcasecontrolstudy
AT ruili anoverlapweightedanalysisontheassociationofconstipationsymptomswithdiseaseprogressionandsurvivalinamyotrophiclateralsclerosisanestedcasecontrolstudy
AT haitaoyang anoverlapweightedanalysisontheassociationofconstipationsymptomswithdiseaseprogressionandsurvivalinamyotrophiclateralsclerosisanestedcasecontrolstudy
AT huidong anoverlapweightedanalysisontheassociationofconstipationsymptomswithdiseaseprogressionandsurvivalinamyotrophiclateralsclerosisanestedcasecontrolstudy
AT yalingliu anoverlapweightedanalysisontheassociationofconstipationsymptomswithdiseaseprogressionandsurvivalinamyotrophiclateralsclerosisanestedcasecontrolstudy
AT tongyangniu overlapweightedanalysisontheassociationofconstipationsymptomswithdiseaseprogressionandsurvivalinamyotrophiclateralsclerosisanestedcasecontrolstudy
AT peizewang overlapweightedanalysisontheassociationofconstipationsymptomswithdiseaseprogressionandsurvivalinamyotrophiclateralsclerosisanestedcasecontrolstudy
AT xiaomengzhou overlapweightedanalysisontheassociationofconstipationsymptomswithdiseaseprogressionandsurvivalinamyotrophiclateralsclerosisanestedcasecontrolstudy
AT tingtingliu overlapweightedanalysisontheassociationofconstipationsymptomswithdiseaseprogressionandsurvivalinamyotrophiclateralsclerosisanestedcasecontrolstudy
AT qiliu overlapweightedanalysisontheassociationofconstipationsymptomswithdiseaseprogressionandsurvivalinamyotrophiclateralsclerosisanestedcasecontrolstudy
AT ruili overlapweightedanalysisontheassociationofconstipationsymptomswithdiseaseprogressionandsurvivalinamyotrophiclateralsclerosisanestedcasecontrolstudy
AT haitaoyang overlapweightedanalysisontheassociationofconstipationsymptomswithdiseaseprogressionandsurvivalinamyotrophiclateralsclerosisanestedcasecontrolstudy
AT huidong overlapweightedanalysisontheassociationofconstipationsymptomswithdiseaseprogressionandsurvivalinamyotrophiclateralsclerosisanestedcasecontrolstudy
AT yalingliu overlapweightedanalysisontheassociationofconstipationsymptomswithdiseaseprogressionandsurvivalinamyotrophiclateralsclerosisanestedcasecontrolstudy